Ocuphire Pharma to Present at the Canaccord 43rd Annual Growth Conference and the H.C. Wainwright Ophthalmology Conference in August
FARMINGTON HILLS, Mich., Aug. 08, 2023 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
News
Theriva™ Biologics Reports Second Quarter 2023 Operational Highlights and Financial Results
– Initiated dosing at U.S. sites for VIRAGE, the Phase 2b clinical trial of VCN-01…
Theriva™ Biologics Reports Second Quarter 2023 Operational Highlights and Financial Results
– Initiated dosing at U.S. sites for VIRAGE, the Phase 2b clinical trial of VCN-01…
Grace Breeding’s Environmentally Friendly WDS Climate Stress Tolerance Solution Receives its First European Product Registration in Germany
– Grace Breeding’s WDS, a proprietary and environmentally friendly formula to counteract crop climate stress,…
Grace Breeding’s Environmentally Friendly WDS Climate Stress Tolerance Solution Receives its First European Product Registration in Germany
– Grace Breeding’s WDS, a proprietary and environmentally friendly formula to counteract crop climate stress,…
Cocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus Lead
First dual coronavirus–norovirus oral antiviral is scheduled for Phase 1 in healthy volunteers In vitro…
Cocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus Lead
First dual coronavirus–norovirus oral antiviral is scheduled for Phase 1 in healthy volunteers In vitro…
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
Organization fully focused on product candidates and collaborations based on next-generation ADC platforms Capital resources…
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
Organization fully focused on product candidates and collaborations based on next-generation ADC platforms Capital resources…
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
Recursion’s Pipeline Recursion’s internal pipeline as of Q2 2023 Deployed new digital chemistry technology, together…
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
Recursion’s Pipeline Recursion’s internal pipeline as of Q2 2023 Deployed new digital chemistry technology, together…
CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update
Conference Call Scheduled for Today at 8:30 a.m. Eastern Time BERKELEY HEIGHTS, N.J., Aug. 08,…
CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update
Conference Call Scheduled for Today at 8:30 a.m. Eastern Time BERKELEY HEIGHTS, N.J., Aug. 08,…
Abeona Therapeutics Reports Second Quarter 2023 Financial Results
On track for Biologics License Application (BLA) submission in third quarter of 2023 Proceeds from…
Abeona Therapeutics Reports Second Quarter 2023 Financial Results
On track for Biologics License Application (BLA) submission in third quarter of 2023 Proceeds from…
Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results
MALVERN, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”)…
Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results
MALVERN, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”)…
XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy
Completed two royalty acquisitions in the first half of 2023 adding one cash flow generating…
XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy
Completed two royalty acquisitions in the first half of 2023 adding one cash flow generating…
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
DURHAM, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the…